RiOciguAt UseRs Registry The ROAR registry
Brief description of study
ROAR is a US-based, multicenter, prospective, uncontrolled, observational study documenting data from about 500 patients with pulmonary arterial hypertension (PAH) and treated with riociguat.
Clinical Study Identifier: s22-00269
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
